4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001450324-17-000003
Options or other derivatives
- CEO / President acquired 300,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Equels Thomas K. · CEO / President
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-06-08 | Other acquisition : show line 1 in the form Options to buy Common Stock | +300,000 | 495,833 | D |
Loading xslF345X03/primary_doc.xml…